December 15, 2025 · Form 4 insider transaction
Tessari Eben bought 6,000 shares of Kiniksa Pharmaceuticals Ltd. at $8.83 per share, a transaction worth $53.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.